AR038390A1 - Proceso para preparar propionato de fluticasona. - Google Patents
Proceso para preparar propionato de fluticasona.Info
- Publication number
- AR038390A1 AR038390A1 ARP030100299A ARP030100299A AR038390A1 AR 038390 A1 AR038390 A1 AR 038390A1 AR P030100299 A ARP030100299 A AR P030100299A AR P030100299 A ARP030100299 A AR P030100299A AR 038390 A1 AR038390 A1 AR 038390A1
- Authority
- AR
- Argentina
- Prior art keywords
- fluticasone propionate
- organic phase
- phase
- solvating
- optionally
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Reivindicación 4: Un proceso para preparar propionato de fluticasona en la forma polimórfica cristalina 1 , que comprende : (a) hacer reaccionar un compuesto de fórmula (1) o una sal del mismo con un compuesto de fórmula LCH2F, en la que L representa un grupo saliente, opcionalmente en presencia de un catalizador de transferencia de fases, un disolvente líquido orgánico no solvatante inmiscible con agua y agua; (b) aumentar opcionalmente la pureza del propionato de fluticasona en la fase orgánica realizando una o más etapas de lavado acuoso; (c) separar la fase orgánica de la fase acuosa y concentrar opcionalmente el propionato de fluticasona en la fase orgánica; (d) mezclar la solución de propionato de fluticasona en el disolvente líquido orgánico no solvatante, inmiscible con agua presente en la fase orgánica con un antidisolvente líquido orgánico no solvatante causando así que el propionato de fluticasona cristalice de la solución en la forma polimórfica cristalina 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0202564.1A GB0202564D0 (en) | 2002-02-04 | 2002-02-04 | Process |
Publications (1)
Publication Number | Publication Date |
---|---|
AR038390A1 true AR038390A1 (es) | 2005-01-12 |
Family
ID=9930366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030100299A AR038390A1 (es) | 2002-02-04 | 2003-01-31 | Proceso para preparar propionato de fluticasona. |
Country Status (22)
Country | Link |
---|---|
US (1) | US20050222107A1 (es) |
EP (1) | EP1474436B1 (es) |
JP (1) | JP2005517019A (es) |
KR (1) | KR20040086331A (es) |
CN (1) | CN100338087C (es) |
AR (1) | AR038390A1 (es) |
AT (1) | ATE446965T1 (es) |
AU (1) | AU2003206836B2 (es) |
BR (1) | BR0307243A (es) |
CA (1) | CA2473896A1 (es) |
CO (1) | CO5611115A2 (es) |
DE (1) | DE60329824D1 (es) |
GB (1) | GB0202564D0 (es) |
IS (1) | IS7373A (es) |
MX (1) | MXPA04007530A (es) |
NO (1) | NO327138B1 (es) |
NZ (1) | NZ534320A (es) |
PL (1) | PL372214A1 (es) |
RU (1) | RU2333218C2 (es) |
TW (1) | TW200410982A (es) |
WO (1) | WO2003066653A2 (es) |
ZA (1) | ZA200405826B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL153462A0 (en) * | 2002-12-16 | 2003-07-06 | Chemagis Ltd | Thiocarboxylic acid organic salts and processes utilizing the same |
PT2044099E (pt) * | 2006-06-14 | 2012-06-06 | Generics Uk Ltd | Processo de preparação s-fluorometil-6,9-difluoro-11- hidroxi-16-metil-17-propioniloxi-3-oxo-androsta-l,4- dieno-17-carbotioato e seus intermediários |
AU2013202835B2 (en) * | 2006-06-14 | 2015-11-12 | Generics [Uk] Limited | Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1, 4-diene-17-carbothioate and intermediates |
WO2012029077A2 (en) * | 2010-09-01 | 2012-03-08 | Cadila Healthcare Limited | Process for preparing fluticasone propionate/furoate |
JP2014520848A (ja) * | 2011-07-08 | 2014-08-25 | ファイザー・リミテッド | 1型プロピオン酸フルチカゾンの調製のための方法 |
CA2872845C (en) | 2012-05-08 | 2021-11-09 | Aciex Therapeutics, Inc. | Preparation of nanocrystals of fluticasone propionate |
US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
DE102012221219B4 (de) * | 2012-11-20 | 2014-05-28 | Jesalis Pharma Gmbh | Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel |
US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2455976A1 (de) * | 1974-11-27 | 1976-08-12 | Merck Patent Gmbh | Prostensaeurederivate |
PH24267A (en) * | 1980-02-15 | 1990-05-29 | Glaxo Group Ltd | Androstane carbothioates and pharmaceutical compositions containing the same |
US5783677A (en) * | 1993-09-24 | 1998-07-21 | Procter & Gamble Pharmaceuticals, Inc. | Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds |
US5488188A (en) * | 1994-09-29 | 1996-01-30 | Merrell Dow Pharmaceuticals Inc. | Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof |
GB9622173D0 (en) * | 1996-10-24 | 1996-12-18 | Glaxo Group Ltd | Particulate Products |
GB9925934D0 (en) * | 1999-11-03 | 1999-12-29 | Glaxo Group Ltd | Novel apparatus and process |
AP1422A (en) * | 2000-08-05 | 2005-06-05 | Glaxo Group Ltd | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent. |
-
2002
- 2002-02-04 GB GBGB0202564.1A patent/GB0202564D0/en not_active Ceased
-
2003
- 2003-01-30 TW TW092102249A patent/TW200410982A/zh unknown
- 2003-01-31 AR ARP030100299A patent/AR038390A1/es not_active Application Discontinuation
- 2003-02-03 US US10/502,866 patent/US20050222107A1/en not_active Abandoned
- 2003-02-03 AT AT03704541T patent/ATE446965T1/de not_active IP Right Cessation
- 2003-02-03 PL PL03372214A patent/PL372214A1/xx unknown
- 2003-02-03 AU AU2003206836A patent/AU2003206836B2/en not_active Ceased
- 2003-02-03 CA CA002473896A patent/CA2473896A1/en not_active Abandoned
- 2003-02-03 JP JP2003566024A patent/JP2005517019A/ja active Pending
- 2003-02-03 EP EP03704541A patent/EP1474436B1/en not_active Expired - Lifetime
- 2003-02-03 DE DE60329824T patent/DE60329824D1/de not_active Expired - Fee Related
- 2003-02-03 WO PCT/EP2003/001115 patent/WO2003066653A2/en active Application Filing
- 2003-02-03 CN CNB038074370A patent/CN100338087C/zh not_active Expired - Fee Related
- 2003-02-03 BR BR0307243-6A patent/BR0307243A/pt not_active IP Right Cessation
- 2003-02-03 NZ NZ534320A patent/NZ534320A/en unknown
- 2003-02-03 KR KR10-2004-7011981A patent/KR20040086331A/ko not_active Application Discontinuation
- 2003-02-03 RU RU2004122928/04A patent/RU2333218C2/ru not_active IP Right Cessation
- 2003-02-03 MX MXPA04007530A patent/MXPA04007530A/es active IP Right Grant
-
2004
- 2004-07-21 ZA ZA200405826A patent/ZA200405826B/en unknown
- 2004-07-26 IS IS7373A patent/IS7373A/is unknown
- 2004-07-30 CO CO04074014A patent/CO5611115A2/es not_active Application Discontinuation
- 2004-09-01 NO NO20043664A patent/NO327138B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IS7373A (is) | 2004-07-26 |
KR20040086331A (ko) | 2004-10-08 |
NO327138B1 (no) | 2009-05-04 |
ZA200405826B (en) | 2005-08-11 |
AU2003206836B2 (en) | 2009-01-08 |
CO5611115A2 (es) | 2006-02-28 |
TW200410982A (en) | 2004-07-01 |
BR0307243A (pt) | 2004-12-14 |
ATE446965T1 (de) | 2009-11-15 |
AU2003206836A1 (en) | 2003-09-02 |
PL372214A1 (en) | 2005-07-11 |
US20050222107A1 (en) | 2005-10-06 |
CN100338087C (zh) | 2007-09-19 |
WO2003066653A2 (en) | 2003-08-14 |
CA2473896A1 (en) | 2003-08-14 |
NZ534320A (en) | 2007-07-27 |
EP1474436A2 (en) | 2004-11-10 |
EP1474436B1 (en) | 2009-10-28 |
MXPA04007530A (es) | 2004-11-10 |
WO2003066653A3 (en) | 2003-12-24 |
GB0202564D0 (en) | 2002-03-20 |
JP2005517019A (ja) | 2005-06-09 |
RU2333218C2 (ru) | 2008-09-10 |
CN1642969A (zh) | 2005-07-20 |
RU2004122928A (ru) | 2005-05-27 |
NO20043664L (no) | 2004-09-01 |
DE60329824D1 (de) | 2009-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2021505614A5 (es) | ||
AR038390A1 (es) | Proceso para preparar propionato de fluticasona. | |
AR035992A1 (es) | Proceso para producir acido tereftalico puro con recuperacion mejorada de precursores, solvente y metil acetato | |
JP2011126894A5 (es) | ||
ES2567081T3 (es) | Producción continua de sales cuaternarias | |
AR063415A1 (es) | Hidratos de clorhidrato de erlotinib para el tratamiento del cancer | |
CN103788069B (zh) | 埃索美拉唑镁三水合物的制备方法 | |
BRPI0616169B8 (pt) | cloridrato de lercanidipina na forma polimorfa v, composição farmacêutica compreendendo dito composto e processos para preparação de cloridrato de lercanidipina | |
HRP20170497T1 (hr) | Postupak dobivanja nalmefen hidroklorida | |
SI2066638T1 (sl) | Postopek za čiščenje montelukasta | |
CN104151249B (zh) | 美托咪定工业化拆分方法 | |
ATE266020T1 (de) | Synthese von r-(+)-alpha-liponsäure | |
BRPI0615131A2 (pt) | preparação de tioalquilaminas com rendimentos elevados | |
CN102887853A (zh) | 一种群多普利中间体的制备方法 | |
CN104311459A (zh) | 一种氧化不对称硫醚制备亚砜的方法 | |
RU2015147242A (ru) | Способ получения арформотерола или его соли | |
CN102757367A (zh) | 一种混旋苯乙磺酸的拆分工艺 | |
CN103351311A (zh) | 一种二苯乙腈的合成方法 | |
AR014939A1 (es) | Proceso para purificar una solucion de un ester profarmaco de ampicilina | |
CN103896842B (zh) | 一种托伐普坦中间体的制备方法 | |
JP2009007257A (ja) | ケルセチン含有植物材料を用いたケルセチンスルホン酸の製造方法 | |
SU502875A1 (ru) | Способ получени метилового эфира 4-диметиламиносалициловой кислоты | |
DE60127455D1 (de) | Verfahren zur herstellung von beta-ketonitrilverbindungen | |
CN105646396A (zh) | 一种苯并噻唑衍生物的合成方法 | |
NZ627247A (en) | Synthesis of calebin-a and its biologically active analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |